Cargando…

Stathmin 1 expression in plasma cell neoplasms

Detalles Bibliográficos
Autores principales:	Machado-Neto, João Agostinho, Pericole, Fernando Vieira, Costa, Fernando Ferreira, Traina, Fabiola, Olalla Saad, Sara Teresinha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457464/ https://www.ncbi.nlm.nih.gov/pubmed/28577660 http://dx.doi.org/10.1016/j.bjhh.2017.02.005

Ejemplares similares

Stathmin 1 in normal and malignant hematopoiesis
por: Machado-Neto, João Agostinho, et al.
Publicado: (2014)

IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes
por: de Melo Campos, Paula, et al.
Publicado: (2018)

Differential profile of CDKN1A and TP53 expressions in bone marrow mesenchymal stromal cells from myeloid neoplasms
por: Lopes, Matheus Rodrigues, et al.
Publicado: (2016)

Somatic mutations of calreticulin in a Brazilian cohort of patients with myeloproliferative neoplasms
por: Machado-Neto, João Agostinho, et al.
Publicado: (2015)

Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2(V617F) cells
por: Machado-Neto, João Agostinho, et al.
Publicado: (2015)

Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms
por: Scopim-Ribeiro, Renata, et al.
Publicado: (2016)

PTK2 and PTPN11 expression in myelodysplastic syndromes
por: Lazarini, Mariana, et al.
Publicado: (2013)

CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells
por: Barbutti, Isabella, et al.
Publicado: (2016)

Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes
por: Machado-Neto, João Agostinho, et al.
Publicado: (2011)

Hematopoietic Cell Kinase (HCK) Is a Player of the Crosstalk Between Hematopoietic Cells and Bone Marrow Niche Through CXCL12/CXCR4 Axis
por: Roversi, Fernanda Marconi, et al.
Publicado: (2021)

Obesity as a Possible Risk Factor for Progression from Monoclonal Gammopathy of Undetermined Significance Progression into Multiple Myeloma: Could Myeloma Be Prevented with Metformin Treatment?
por: da Cunha Júnior, Ademar Dantas, et al.
Publicado: (2021)

Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells
por: Machado-Neto, João Agostinho, et al.
Publicado: (2017)

De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
por: Lopes, Matheus Rodrigues, et al.
Publicado: (2017)

Reactive oxygen species overload promotes apoptosis in JAK2V617F-positive cell lines()
por: Machado-Neto, João Agostinho, et al.
Publicado: (2016)

Myelodysplastic syndrome with synchronous gastric cancer: when the symptoms suggest something else
por: de Melo Campos, Paula, et al.
Publicado: (2014)

IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2(V617F)-positive myeloproliferative neoplasms
por: de Melo Campos, Paula, et al.
Publicado: (2016)

Identification of protein-coding and non-coding RNA expression profiles in CD34(+ )and in stromal cells in refractory anemia with ringed sideroblasts
por: Baratti, Mariana O, et al.
Publicado: (2010)

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Pericole, Fernando Vieira, et al.
Publicado: (2019)

Up‐regulation of SPINT2/HAI‐2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion
por: Roversi, Fernanda Marconi, et al.
Publicado: (2018)

Low bone mass density is associated with hemolysis in brazilian patients with sickle cell disease
por: Baldanzi, Gabriel, et al.
Publicado: (2011)

Reversine exhibits antineoplastic activity in JAK2(V617F)-positive myeloproliferative neoplasms
por: Lima, Keli, et al.
Publicado: (2019)

CXCR7 Is Highly Expressed in Acute Lymphoblastic Leukemia and Potentiates CXCR4 Response to CXCL12
por: Melo, Rita de Cássia Carvalho, et al.
Publicado: (2014)

Cellular and Molecular Effects of Eribulin in Preclinical Models of Hematologic Neoplasms
por: Vicari, Hugo Passos, et al.
Publicado: (2022)

Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients
por: Kuang, Xia-Ying, et al.
Publicado: (2015)

Stathmin Is Dispensable for Tumor Onset in Mice
por: D’Andrea, Sara, et al.
Publicado: (2012)

CXCR7 participates in CXCL12-mediated migration and homing of leukemic and normal hematopoietic cells
por: Melo, Rita de Cassia Carvalho, et al.
Publicado: (2018)

Current highlights on solid pseudopapillary neoplasm of the pancreas
por: Sibio, Simone, et al.
Publicado: (2022)

Plasma Membrane Redox System in the Erythrocytes of Rowers: Pilot Study
por: Di MAJO, Danila, et al.
Publicado: (2017)

HIV-1 exposure triggers autophagic degradation of stathmin and hyperstabilization of microtubules to disrupt epithelial cell junctions
por: Xie, Wei, et al.
Publicado: (2020)

Discolouration of plasma in therapeutic plasma exchange
por: Bala Kumar, SS Deepak, et al.
Publicado: (2021)

A Survey Conducted during COVID-19 Pandemic Among Brazilian Chronic Myeloid Leukemia and Philadelphia-Negative Myeloproliferative Neoplasms Patients
por: Fechio, Leonardo, et al.
Publicado: (2021)

Motivating medical students to learn basic science concepts using chronic myeloid leukemia as an integration theme
por: Saad, Sara Teresinha Olalla, et al.
Publicado: (2015)

Survival of patients diagnosed with subsets of lymphoid neoplasms and acute myeloid leukemia from 2000 to 2010 in the Vale do Paraíba, State of São Paulo are we going the right way?
por: Callera, Fernando, et al.
Publicado: (2012)

Stathmin drives virus-induced metastasis
por: Whitehouse, Adrian, et al.
Publicado: (2015)

The JAK2 gene as a protagonist in chronic myeloproliferative neoplasms
por: de Freitas, Renata Mendes, et al.
Publicado: (2013)

Evaluation of different protocols for culturing mesenchymal stem cells derived from murine bone marrow
por: Pissarra, Mariana Ferreira, et al.
Publicado: (2022)

IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosis
por: Cumbo, Cosimo, et al.
Publicado: (2021)

Hypercalcemia as a biomarker of myeloproliferative neoplasms?
por: Langabeer, Stephen E.
Publicado: (2019)

Neglected malignant neoplasms with cutaneous involvement
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2021)

Dual Drivers in the Myeloproliferative Neoplasms: An Underestimation?
por: Langabeer, Stephen E.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9uidp1qeem8mn8nv9n4528n73p